Franklin Resources Inc Assembly Biosciences, Inc. Transaction History

Franklin Resources Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.87 - $1.13 $15,010 - $19,495	-17,253 Reduced 20.88%	65,392 $58,000
Q4 2022 Feb 10, 2023	BUY	$1.09 - $20.4 $48,484 - $907,412	44,481 Added 116.55%	82,645 $107,000
Q3 2022 Nov 14, 2022	BUY	$1.7 - $20.52 $712 - $8,597	419 Added 1.11%	38,164 $63,000
Q2 2022 Aug 11, 2022	SELL	$1.35 - $2.29 $24,644 - $41,803	-18,255 Reduced 32.6%	37,745 $79,000
Q1 2022 May 13, 2022	SELL	$1.46 - $2.45 $771,884 - $1.3 Million	-528,688 Reduced 90.42%	56,000 $115,000
Q3 2021 Nov 12, 2021	BUY	$3.14 - $3.9 $175,840 - $218,400	56,000 Added 10.59%	584,688 $2.04 Million
Q2 2021 Aug 13, 2021	SELL	$3.8 - $4.56 $1.45 Million - $1.74 Million	-381,389 Reduced 41.91%	528,688 $2.05 Million
Q1 2021 May 13, 2021	BUY	$4.33 - $6.63 $407 - $623	94 Added 0.01%	910,077 $4.19 Million
Q4 2020 Feb 10, 2021	BUY	$4.87 - $17.29 $1.49 Million - $5.28 Million	305,183 Added 50.46%	909,983 $5.51 Million
Q1 2020 May 13, 2020	SELL	$10.27 - $21.23 $1.23 Million - $2.55 Million	-120,000 Reduced 16.56%	604,800 $8.97 Million
Q4 2019 Feb 12, 2020	BUY	$8.36 - $23.81 $6.06 Million - $17.3 Million	724,800 New	724,800 $14.8 Million
Q2 2019 Aug 14, 2019	SELL	$12.9 - $20.8 $2.58 Million - $4.16 Million	-200,000 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$19.05 - $36.45 $1.08 Million - $2.06 Million	-56,448 Reduced 22.01%	200,000 $4.52 Million
Q3 2018 Nov 13, 2018	BUY	$34.41 - $44.23 $8.82 Million - $11.3 Million	256,448 New	256,448 $9.52 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $737M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.